• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

- [V(O)(Cl/F)(N)] 物种模拟金属酶活性中心的氧化催化作用的实验与理论综合研究。

A Combined Experimental and Theoretical Investigation of Oxidation Catalysis by -[V(O)(Cl/F)(N)] Species Mimicking the Active Center of Metal-Enzymes.

机构信息

Section of Inorganic and Analytical Chemistry, Department of Chemistry, University of Ioannina, Ioannina45110, Greece.

Department of Chemistry, University of Cyprus, Nicosia1678, Cyprus.

出版信息

Inorg Chem. 2022 Nov 21;61(46):18434-18449. doi: 10.1021/acs.inorgchem.2c02526. Epub 2022 Nov 10.

DOI:10.1021/acs.inorgchem.2c02526
PMID:36357045
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9682486/
Abstract

Reaction of VOCl with the nonplanar tetradentate N bis-quinoline ligands yielded four oxidovanadium(IV) compounds of the general formula -[V(O)(Cl)(N)]Cl. Sequential treatment of the two nonmethylated N oxidovanadium(IV) compounds with KF and NaClO resulted in the isolation of the species with the general formula -[V(O)(F)(N)]ClO. In marked contrast, the methylated N oxidovanadium(IV) derivatives are inert toward KF reaction due to steric hindrance, as evidenced by EPR and theoretical calculations. The oxidovanadium(IV) compounds were characterized by single-crystal X-ray structure analysis, cw EPR spectroscopy, and magnetic susceptibility. The crystallographic characterization showed that the vanadium compounds have a highly distorted octahedral coordination environment and the (V-F) = 1.834(1) Å is the shortest to be reported for (oxido)(fluorido)vanadium(IV) compounds. The experimental EPR parameters of the VO species deviate from the ones calculated by the empirical additivity relationship and can be attributed to the axial donor atom trans to the oxido group and the distorted V coordination environment. The vanadium compounds act as catalysts toward alkane oxidation by aqueous HO with moderate ΤΟΝ up to 293 and product yields of up to 29% (based on alkane); the vanadium(IV) is oxidized to vanadium(V), and the ligands remain bound to the vanadium atom during the catalysis, as determined by V and H NMR spectroscopies. The cw X-band EPR studies proved that the mechanism of the catalytic reaction is through hydroxyl radicals. The chloride substitution reaction in the -[V(O)(Cl)(N)] species by fluoride and the mechanism of the alkane oxidation were studied by DFT calculations.

摘要

VOCl 与非平面四齿 N-双喹啉配体反应生成了四个氧化钒(IV)化合物,通式为-[V(O)(Cl)(N)]Cl。对两个未甲基化的 N-氧化钒(IV)化合物进行连续处理,用 KF 和 NaClO 处理,得到了通式为-[V(O)(F)(N)]ClO 的物种。相比之下,由于空间位阻,甲基化的 N-氧化钒(IV)衍生物对 KF 反应是惰性的,这一点可以通过 EPR 和理论计算得到证明。氧化钒(IV)化合物通过单晶 X 射线结构分析、连续波 EPR 光谱和磁化率进行了表征。晶体学表征表明,钒化合物具有高度扭曲的八面体配位环境,(V-F)=1.834(1) Å 是迄今为止报道的(氧化)(氟化物)氧化钒(IV)化合物中最短的。VO 物种的实验 EPR 参数偏离了经验加和关系计算出的参数,可以归因于轴向给体原子反式的 oxido 基团和扭曲的 V 配位环境。这些钒化合物在水中 HO 存在下作为烷烃氧化的催化剂,TON 高达 293,产物收率高达 29%(基于烷烃);钒(IV)被氧化为钒(V),配体在催化过程中仍与钒原子结合,这可以通过 V 和 H NMR 光谱确定。连续波 X 波段 EPR 研究证明了催化反应的机制是通过羟基自由基。通过 DFT 计算研究了-[V(O)(Cl)(N)]物种中氯离子的取代反应和烷烃氧化的机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2825/9682486/c829b83793cf/ic2c02526_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2825/9682486/3bdfcbc1c420/ic2c02526_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2825/9682486/be7de5bfc9c9/ic2c02526_0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2825/9682486/28a887d73ff5/ic2c02526_0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2825/9682486/95721accbfbd/ic2c02526_0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2825/9682486/24eaaf4374eb/ic2c02526_0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2825/9682486/6ee20ab819d5/ic2c02526_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2825/9682486/c21ffc19a004/ic2c02526_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2825/9682486/ed5081e9d644/ic2c02526_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2825/9682486/2452c152b5ee/ic2c02526_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2825/9682486/b095496baddb/ic2c02526_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2825/9682486/a52aa0c4bc4c/ic2c02526_0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2825/9682486/652a552278e4/ic2c02526_0016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2825/9682486/d3cb56e1b000/ic2c02526_0017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2825/9682486/18712d652878/ic2c02526_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2825/9682486/9c35fe1c779b/ic2c02526_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2825/9682486/d2bf4b3d7139/ic2c02526_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2825/9682486/c829b83793cf/ic2c02526_0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2825/9682486/3bdfcbc1c420/ic2c02526_0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2825/9682486/be7de5bfc9c9/ic2c02526_0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2825/9682486/28a887d73ff5/ic2c02526_0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2825/9682486/95721accbfbd/ic2c02526_0013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2825/9682486/24eaaf4374eb/ic2c02526_0014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2825/9682486/6ee20ab819d5/ic2c02526_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2825/9682486/c21ffc19a004/ic2c02526_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2825/9682486/ed5081e9d644/ic2c02526_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2825/9682486/2452c152b5ee/ic2c02526_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2825/9682486/b095496baddb/ic2c02526_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2825/9682486/a52aa0c4bc4c/ic2c02526_0015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2825/9682486/652a552278e4/ic2c02526_0016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2825/9682486/d3cb56e1b000/ic2c02526_0017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2825/9682486/18712d652878/ic2c02526_0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2825/9682486/9c35fe1c779b/ic2c02526_0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2825/9682486/d2bf4b3d7139/ic2c02526_0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2825/9682486/c829b83793cf/ic2c02526_0009.jpg

相似文献

1
A Combined Experimental and Theoretical Investigation of Oxidation Catalysis by -[V(O)(Cl/F)(N)] Species Mimicking the Active Center of Metal-Enzymes.- [V(O)(Cl/F)(N)] 物种模拟金属酶活性中心的氧化催化作用的实验与理论综合研究。
Inorg Chem. 2022 Nov 21;61(46):18434-18449. doi: 10.1021/acs.inorgchem.2c02526. Epub 2022 Nov 10.
2
Synthesis, characterization, reactivity and catalytic activity of oxidovanadium(IV), oxidovanadium(V) and dioxidovanadium(V) complexes of benzimidazole modified ligands.苯并咪唑修饰配体的氧化钒(IV)、氧化钒(V)和二氧代钒(V)配合物的合成、表征、反应性和催化活性。
Dalton Trans. 2011 Jul 14;40(26):6968-83. doi: 10.1039/c1dt10261c. Epub 2011 Jun 7.
3
The effect of charged axial ligands on the EPR parameters in oxovanadium(IV) compounds: an unusual reduction of the Az (51V) values.带电荷的轴向配体对氧钒(IV)化合物中电子顺磁共振参数的影响:Az(51V)值的异常降低
Chemistry. 2001 Jun 18;7(12):2698-710. doi: 10.1002/1521-3765(20010618)7:12<2698::aid-chem26980>3.0.co;2-2.
4
Model investigations for vanadium-protein interactions: vanadium(III) compounds with dipeptides and their oxovanadium(IV) analogues.钒与蛋白质相互作用的模型研究:钒(III)与二肽的化合物及其氧钒(IV)类似物。
J Biol Inorg Chem. 2002 Apr;7(4-5):363-74. doi: 10.1007/s00775-001-0308-0. Epub 2001 Nov 30.
5
Oxidovanadium(IV) Schiff base complex derived from vitamin B6: synthesis, characterization, and insulin enhancing properties.基于维生素 B6 的氧化钒(IV)希夫碱配合物的合成、表征及胰岛素增强特性。
Inorg Chem. 2011 May 16;50(10):4349-61. doi: 10.1021/ic102412s. Epub 2011 Apr 15.
6
N,N'-ethylenebis(pyridoxylideneiminato) and N,N'-ethylenebis(pyridoxylaminato): synthesis, characterization, potentiometric, spectroscopic, and DFT studies of their vanadium(IV) and vanadium(V) complexes.N,N'-亚乙基双(吡啶甲醛亚胺基)和N,N'-亚乙基双(吡啶胺基):其钒(IV)和钒(V)配合物的合成、表征、电位滴定、光谱及密度泛函理论研究
Chemistry. 2004 May 3;10(9):2301-17. doi: 10.1002/chem.200305317.
7
Unexpected synthesis of an unsymmetrical mu-oxido divanadium(V) compound through a reductive cleavage of a N-O bond and cleavage-hydrolysis of a C-N bond of an N,N-disubstituted bis-(hydroxylamino) ligand.通过还原裂解 N,O 键和裂解水解 N,N-二取代双(羟氨基)配体的 C-N 键,意外合成了一个不对称的μ-氧代二钒(V)化合物。
Inorg Chem. 2010 Jan 4;49(1):52-61. doi: 10.1021/ic901809f.
8
Vanadium thiolate complexes for efficient and selective sulfoxidation catalysis: a mechanistic investigation.用于高效和选择性氧化催化的硫代钒配合物:机理研究。
Inorg Chem. 2013 Dec 2;52(23):13424-31. doi: 10.1021/ic4017504. Epub 2013 Nov 13.
9
Vanadium complexes having [V(IV)O](2+) and [V(V)O(2)](+) cores with binucleating dibasic tetradentate ligands: Synthesis, characterization, catalytic and antiamoebic activities.具有 [V(IV)O](2+) 和 [V(V)O(2)](+) 核的钒配合物与双核双基四齿配体:合成、表征、催化和抗阿米巴活性。
Dalton Trans. 2010 Feb 7;39(5):1345-60. doi: 10.1039/b915752b. Epub 2009 Dec 1.
10
Synthesis, characterization, reactivity, and catalytic potential of model vanadium(IV, V) complexes with benzimidazole-derived ONN donor ligands.具有苯并咪唑衍生的ONN供体配体的钒(IV,V)模型配合物的合成、表征、反应活性及催化潜力
Inorg Chem. 2006 Jul 24;45(15):5924-37. doi: 10.1021/ic0604922.

引用本文的文献

1
Experimental and Theoretical Investigation of the Mechanism of the Reduction of O from Air to O by VO-,,-Amidate Compounds and Their Potential Use in Fuel Cells.VO-酰胺化合物将空气中的O还原为O的机理的实验与理论研究及其在燃料电池中的潜在应用
Inorg Chem. 2024 Feb 19;63(7):3229-3249. doi: 10.1021/acs.inorgchem.3c03272. Epub 2024 Feb 5.

本文引用的文献

1
Vanadium-Flavonoid Complexes: A Promising Class of Molecules for Therapeutic Applications.钒-类黄酮配合物:一类有前途的治疗应用的分子。
J Med Chem. 2021 Sep 9;64(17):12435-12452. doi: 10.1021/acs.jmedchem.1c00405. Epub 2021 Aug 25.
2
Vanadium: Risks and possible benefits in the light of a comprehensive overview of its pharmacotoxicological mechanisms and multi-applications with a summary of further research trends.钒:综合其药理毒理机制和多方面应用的全面概述,以及对进一步研究趋势的总结,探讨其风险和可能的益处。
J Trace Elem Med Biol. 2020 Sep;61:126508. doi: 10.1016/j.jtemb.2020.126508. Epub 2020 Apr 12.
3
Molecular and Cellular Mechanisms of Cytotoxic Activity of Vanadium Compounds against Cancer Cells.
钒化合物对癌细胞细胞毒性作用的分子和细胞机制。
Molecules. 2020 Apr 10;25(7):1757. doi: 10.3390/molecules25071757.
4
Second-Coordination Sphere Effect on the Reactivity of Vanadium-Peroxo Complexes: A Computational Study.第二配位层对钒过氧配合物反应活性的影响:计算研究。
Inorg Chem. 2019 Dec 2;58(23):15741-15750. doi: 10.1021/acs.inorgchem.9b01778. Epub 2019 Nov 13.
5
Emergence of metal selectivity and promiscuity in metalloenzymes.金属酶中金属选择性和多功能性的出现。
J Biol Inorg Chem. 2019 Jun;24(4):517-531. doi: 10.1007/s00775-019-01667-0. Epub 2019 May 21.
6
Developing Vanadium as an Antidiabetic or Anticancer Drug: A Clinical and Historical Perspective.将钒开发为抗糖尿病或抗癌药物:临床与历史视角
Met Ions Life Sci. 2019 Jan 14;19. doi: 10.1515/9783110527872-014.
7
Vanadium in Biological Action: Chemical, Pharmacological Aspects, and Metabolic Implications in Diabetes Mellitus.钒在生物作用中的作用:化学、药理学方面以及糖尿病中的代谢影响。
Biol Trace Elem Res. 2019 Mar;188(1):68-98. doi: 10.1007/s12011-018-1540-6. Epub 2018 Oct 22.
8
Catalytic Applications of Vanadium: A Mechanistic Perspective.钒的催化应用:一种机理视角。
Chem Rev. 2019 Feb 27;119(4):2128-2191. doi: 10.1021/acs.chemrev.8b00245. Epub 2018 Oct 8.
9
Coordination environment changes of the vanadium in vanadium-dependent haloperoxidase enzymes.钒依赖卤过氧化物酶中钒的配位环境变化。
J Inorg Biochem. 2018 Sep;186:267-279. doi: 10.1016/j.jinorgbio.2018.06.011. Epub 2018 Jun 18.
10
A bound reaction intermediate sheds light on the mechanism of nitrogenase.结合态反应中间体揭示了固氮酶的作用机制。
Science. 2018 Mar 30;359(6383):1484-1489. doi: 10.1126/science.aar2765.